EUVIMEDEUVIMED entdecken
Open Access

Complement C3a Receptor 1 and Complement C5a Receptor 1 Are Dual Contributors of Chronic-Plus-Binge–Induced Hepatic Inflammation and Injury

Lauren N Rutt, Shannon M Kirkpatrick, Paige E Anton, Andrew Winter, Courtney Capper, Matthew A Burchill, Kristofer S Fritz, Rebecca L McCullough

The American Journal of Pathology · 2026

DOI: 10.1016/j.ajpath.2026.04.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2026. Verfasst von Lauren N Rutt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora,…. Hauptthemen laut MEDLINE: Receptor, Anaphylatoxin C5a, Receptors, Complement, Inflammation, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIDDK NIH HHS, National Institute of Environmental Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Anaphylatoxin C5aReceptors, ComplementInflammationLiver Diseases, AlcoholicAnimalsMiceHumansMaleMice, KnockoutMice, Inbred C57BLLiverMacrophagesKupffer CellsEthanol

Substanzen

Receptor, Anaphylatoxin C5aReceptors, Complementcomplement C3a receptorC5ar1 protein, mouseEthanol

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Department of Gastroenterology and Hepatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; GI and Liver Innate Immune Program, School of Medicine, University of Colorado Anschut…
  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Alcohol Research Program, University of Colorado Anschutz M…
  • Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado; GI and Liver Innate Immune Program, School of Medicine, Uni…

Förderung

  • NIAAA NIH HHS
  • NIDDK NIH HHS
  • National Institute of Environmental Health Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Alcohol Abuse and Alcoholism
  • University of Colorado
  • National Institutes of Health

Zitieren

APA

Rutt, L. N., Kirkpatrick, S. M., Anton, P. E., Winter, A., Capper, C., Burchill, M. A., Fritz, K. S., & McCullough, R. L. (2026). Complement C3a Receptor 1 and Complement C5a Receptor 1 Are Dual Contributors of Chronic-Plus-Binge–Induced Hepatic Inflammation and Injury. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2026.04.019

Vancouver

Rutt LN, Kirkpatrick SM, Anton PE, Winter A, Capper C, Burchill MA, et al. Complement C3a Receptor 1 and Complement C5a Receptor 1 Are Dual Contributors of Chronic-Plus-Binge–Induced Hepatic Inflammation and Injury. The American Journal of Pathology. 2026. doi:10.1016/j.ajpath.2026.04.019

BibTeX
@article{Rutt2026,
  author = {Rutt, Lauren N and Kirkpatrick, Shannon M and Anton, Paige E and Winter, Andrew and Capper, Courtney and Burchill, Matthew A and Fritz, Kristofer S and McCullough, Rebecca L},
  title = {Complement C3a Receptor 1 and Complement C5a Receptor 1 Are Dual Contributors of Chronic-Plus-Binge–Induced Hepatic Inflammation and Injury},
  journal = {The American Journal of Pathology},
  year = {2026},
  doi = {10.1016/j.ajpath.2026.04.019}
}
Kostenlos starten →